Suppr超能文献

[术后恶心呕吐]

[Postoperative nausea and vomiting].

作者信息

Apfel C C, Roewer N

机构信息

Department of Anesthesiology and Perioperative Medicine, Outcomes Research Institute, University of Louisville, KY 40202, USA.

出版信息

Anaesthesist. 2004 Apr;53(4):377-89; quiz 390-1. doi: 10.1007/s00101-004-0662-8.

Abstract

Numerous pathophysiological mechanisms are known to cause nausea or vomiting but their role for postoperative nausea and vomiting (PONV) is not quite clear. Volatile anesthetics, nitrous oxide and opioids appear to be the most important causes for PONV. Female gender, non-smoking and a history of motion sickness and PONV are the most important patient specific risk factors. With these risk factors an objective risks assessment is achievable as a good rational basis for a risk dependent antiemetic approach: When the risk is low, moderate, or high, the use of none, a single or a combination of prophylactic antiemetic interventions seems to be justified. Performing a total intravenous anesthesia (Ti.v.A) with propofol is a reasonable prophylactic approach, but does not solve the problem satisfactorily alone if the risk is very high, reducing the risk of PONV only by 30%. This is comparable to the reduction rate of antiemetics, such as serotonin antagonist, dexamethasone and droperidol. It must be stressed that metoclopramide is ineffective. Data from IMPACT indicate that prophylaxis is not very effective if the patients risk is low. At a moderate risk the use of Ti.v.A or an antiemetic is reasonable and only a (very) high risk justifies the combination of several prophylactic antiemetic interventions. For the treatment of PONV an antiemetic should be chosen which has not been used prophylactically. The necessary doses are usually a quarter of those needed for prophylaxis.

摘要

已知多种病理生理机制可导致恶心或呕吐,但其在术后恶心呕吐(PONV)中的作用尚不完全清楚。挥发性麻醉剂、氧化亚氮和阿片类药物似乎是PONV的最重要原因。女性、不吸烟以及晕动病和PONV病史是最重要的患者特异性危险因素。有了这些危险因素,就可以进行客观的风险评估,为基于风险的止吐方法提供良好的合理依据:当风险低、中或高时,不使用、单一使用或联合使用预防性止吐干预措施似乎是合理的。使用丙泊酚进行全静脉麻醉(Ti.v.A)是一种合理的预防方法,但如果风险非常高,单独使用并不能令人满意地解决问题,只能将PONV风险降低30%。这与5-羟色胺拮抗剂、地塞米松和氟哌利多等止吐药的降低率相当。必须强调的是,胃复安无效。IMPACT的数据表明,如果患者风险低,预防效果不太好。在中度风险时,使用Ti.v.A或止吐药是合理的,只有(非常)高风险才需要联合使用多种预防性止吐干预措施。对于PONV的治疗,应选择一种未用于预防的止吐药。所需剂量通常是预防所需剂量的四分之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验